Of the 6 patients, three had a final diagnosis of glioblastoma, wherein two had an initial presentation of CASPR2 and seronegative autoimmune encephalitis, 1.5 and 3 years preceding the final diagnosis, respectively while the third had concomitant AQP4 antibody positivity. One patient, diagnosed as primary CNS lymphoma, had an initial picture of MOG positive demyelination resistant to immune therapy with multiple relapses over 4-month period prior to the final diagnosis. One patient had an initial seronegative NMO spectrum disorder like presentation with optic neuritis and longitudinally extensive transverse myelitis, but finally diagnosed as H3K27 mutant diffuse midline glioma. One had undiagnosed myasthenia gravis, for 1 year prior to his subsequent diagnosis of Oligodendroglioma and post-surgical evaluation confirmed Acetylcholine receptor antibody positive myasthenia gravis.